
WHO Conference in Geneva to Decide Future of CBD Regulation
The WHO conference in Geneva is evaluating CBD's future regulation, potentially impacting its global accessibility and classification as a medical substance
- •WHO conference in Geneva discusses CBD regulation
- •CBD could be classified as a medical substance, limiting access
- •Activists advocate for CBD to remain a dietary supplement
by sort-cbd-entre-mains-oms



















